KRYS

Krystal Biotech, Inc.

Health Care
52
/100
HOLD
Signal 2.0 composite score — 7-pillar quant rating updated daily.

Signal 2.0

7-Pillar Score Breakdown

Each pillar scores 0–100. The composite is a regime-weighted blend of all seven.

Fundamentals & Quality
79
Valuation
28
Technicals & Momentum
78
Sentiment & News
2
Earnings Quality
53
Risk Profile
64
Market Regime
50

Premium Insights

Deeper Analysis — Unlocking Soon

Advanced institutional-grade signals are coming to Quantex Premium. Join the waitlist for early access.

Institutional Flow Signal ★ PREMIUM
🔒 PREMIUM Unlock with Premium
Earnings Risk Score ★ PREMIUM
73
Risk Score / 100
MODERATE
EPS Beat Est.
Report in ~14 days
🔒 PREMIUM Unlock with Premium

Fundamentals

Key Metrics

Sourced from the daily universe scan. Open the terminal for the full financial deep-dive.

Market Cap
$10.0B
P/E Ratio
48.6x
Revenue Growth
+104.5%
EPS Growth
+52.5%
Profit Margin
53.9%
Beta
0.50

See the full picture for KRYS.

Run live Signal 2.0 scoring, deep financial statements, DCF valuation, CAPM, and options pricing — free, no account required.

Open Full Analysis → Browse All Stocks